Merit Medical Systems | MMSI - Ebitda


Merit Medical Systems reported $83.96M in EBITDA for its fiscal quarter ending in June of 2025.





Ebitda Change Date
3M USD 1.68B 227M Sep/2025
Abbott USD 3.09B 44M Sep/2025
AngioDynamics USD -369K 2.01M Feb/2025
Anika Therapeutics USD -2.69M 4.73M Mar/2025
AtriCure USD 19.86M 2.06M Dec/2025
Baxter International USD 426M 36M Sep/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.37B 1000K Sep/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Dexcom USD 422.2M 53.8M Dec/2025
Edwards Lifesciences USD 464.3M 4.7M Sep/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Haemonetics USD 115.53M 9.22M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
ICU Medical USD 98.19M 27.67M Dec/2025
Insulet USD 194M 34M Dec/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
J&J USD 9.52B 389M Sep/2025
Medtronic USD 2.93B 482M Dec/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Olympus JPY 45.72B 4.58B Dec/2025
Pfizer USD 6.08B 351M Sep/2025
STAAR Surgical USD 34.62M 49.56M Sep/2025
Stryker USD 1.67B 206M Sep/2025
Surmodics USD 1.53M 485K Sep/2024
Tandem Diabetes Care USD 32.9M 30.13M Dec/2025
Teleflex USD 207.62M 15.28M Jun/2025
Terumo JPY 69.99B 3.22B Dec/2025
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025